🇺🇸 FDA
Patent

US 10787419

Cannabinoid receptor mediating iminopyrazole compounds

granted A61PA61P3/04A61P3/10

Quick answer

US patent 10787419 (Cannabinoid receptor mediating iminopyrazole compounds) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P3/04, A61P3/10, A61P35/00